Table 2.
Characteristics of included guidelines.
| Source | Title | Country | Year | Issuing organisation |
|---|---|---|---|---|
| Agency for Health Care Policy and Research Practice Guidelines (AHCPR) | Treating major depression in primary care practice – an update of the Agency for Health Care Policy and Research Practice Guidelines 32 | US | 1998 | National health service |
| American Academy of Child and Adolescent Psychiatry (AACAP) | Practice parameter for the assessment and treatment of children and adolescents with depressive disorders 48 | US | 2007 | Professional society |
| American Academy of Pediatrics (AAP) | Guidelines for adolescent depression in primary care (GLAD-PC)): Part I. Practice preparation, identification, assessment and initial management + Part II. Treatment and ongoing management 26 | US | 2018 | Patient organisation + commercial company |
| American Psychological Association (APA) | Clinical practice guideline for the treatment of depression across three cohorts 29 | US | 2019 | Professional society |
| American Psychiatric Association (APA) | Practice guideline for the treatment of patients with major depressive disorder Third Edition 28 | US | 2010 | Professional society |
| American College of Physicians (ACP) | Nonpharmacologic versus pharmacologic treatment of adult patients with major depressive disorder: A clinical practice guideline from the American College of Physicians 30 | US | 2016 | Professional society |
| British Association for Psychopharmacology (BAP) | Evidence-based guidelines for treating depressive disorders with antidepressants: A revision of the 2008 British Association for Psychopharmacology guidelines 2 | UK | 2015 | Professional society |
| National Collaborating Centre for Mental Health (NCCMH) | Depression: The NICE guideline on the treatment and management of depression in adults – updated edition 36 | UK | 2019 | Professional society |
| Canadian Network for Mood and Anxiety Treatments (CANMAT) | Canadian network for mood and anxiety treatments (CANMAT) 2016 clinical guidelines for the management of adults with major depressive disorder: Section 3. Pharmacological Treatments 37 | Ca | 2016 | Professional organisation |
| Department of Veteran Affairs and Department of Defense (VA/DoD) and The Management of Major Depressive Disorder Working Group | VA/DoD Clinical practice guideline for the management of major depressive disorder 27 | US | 2016 | Government |
| Health Service Executive (HSE) and Irish College of General Practitioners (ICGP) | Guidelines for the management of depression and anxiety disorders in primary care 42 | Ir | 2006 | Professional society |
| Ministry of Health Singapore | Depression 41 | Si | 2012 | National health authority |
| National Institute for Health and Care Excellence (NICE) | Depression in adults – recognition and management 1 | UK | 2009 | Government |
| New Zealand Guidelines Group (NZGG) and Ministry of Health New Zealand | Identification of common mental disorders and management of depression in primary care 39 | NZ | 2008 | Government |
| National Institute for Health and Care Excellence (NICE) | Depression in children and young people – identification and management 33 | UK | 2019 | Government |
| Royal Australian and New Zealand College of Psychiatrists (RANZCP) | The 2020 Royal Australian and New Zealand College of Psychiatrists clinical practice guidelines for mood disorders 3 | Aus, NZ | 2020 | Professional society |
| Royal College of Psychiatrists (RCPSYCH) and the Faculty of Old Age Psychiatry Working Group | Guideline for the management of late-life depression in primary care 35 | UK | 2003 | Professional society |
| Scottish Intercollegiate Guidelines Network (SIGN) and Healthcare Improvement Scotland (HSE) | Management of perinatal mood disorders 40 | Sc | 2012 | Government |
| World Federation of Societies of Biological Psychiatry (WFSBP) | World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for biological treatment of unipolar depressive disorders, Part 1: Update 2013 on the acute and continuation treatment of unipolar depressive disorders + Part 2: Maintenance treatment of major depressive disorder – update 201544 | Int | 2013 + 2015 | Professional organisation |
| World Federation of Societies of Biological Psychiatry (WFSBP) | Guidelines for biological treatment of unipolar depressive disorders in primary care 45 | Int | 2007 | Professional society |
| World Health Organization (WHO) | Mental Health Gap Action Programme (mhGAP) Intervention Guide for mental, neurological and substance use disorders in non-specialized health settings (2016) + WHO mhGAP Guideline Update (2015) 47 | Int | 2015 + 2016 | NGO |
Aus, Australia; Ca, Canada; Int, international; Ir, Ireland; mhGAP, Mental Health Gap Action Programme; NGO, non-governmental organisation; NZ, New Zealand; UK, the United Kingdom; US, the United States of America; Sc, Scotland; Si, Singapore.